Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations.
about
Some of the challenges in drug development for irritable bowel syndromeIntestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected ratRole of antispasmodics in the treatment of irritable bowel syndrome.Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients.Principles of applied neurogastroenterology: physiology/motility-sensation.Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicineNutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses.Current insights in to the pathophysiology of Irritable Bowel Syndrome.Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain.Pharmacology and clinical experience with fedotozine.Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Visceral afferent contributions to the pathobiology of visceral pain.Visceral nociception.Memory in the enteric nervous system.Postoperative ileus: a preventable event.Duodenal intraepithelial T lymphocytes in patients with functional dyspepsia.Irritable bowel syndrome: a review article.Irritable bowel syndrome: an update on therapeutic modalities.Pathogenesis of colonic diverticula.Guidelines on the irritable bowel syndrome: mechanisms and practical management.A role for inflammation in irritable bowel syndrome?Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome.Serotonergic modulation of visceral sensation: upper gastrointestinal tract.Pharmacotherapy: non-serotonergic mechanisms.Sensory neurone responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain.Chemical nociception in the jejunum induced by capsaicin.Experimental pain in gastroenterology: a reappraisal of human studies.Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets.Irritable bowel syndrome: a review and updateEffects of tegaserod on Fos, substance P and calcitonin gene-related peptide expression induced by colon inflammation in lumbarsacral spinal cord.Adenosine 5'-triphosphate and its relationship with other mediators that activate pelvic nerve afferent neurons in the rat colorectum.Functional gastrointestinal disorders and mast cells: implications for therapy.Drugs affecting visceral sensitivity: ready for the prime time?Central serotonergic and noradrenergic receptors in functional dyspepsia.Experimental human pain models in gastro-esophageal reflux disease and unexplained chest painElectroacupuncture alleviates stress-induced visceral hypersensitivity through an opioid system in ratsHistopathological alterations in irritable bowel syndrome.Hind paw incision in the rat produces long-lasting colon hypersensitivityTryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome.Visceral Hypersensitivity Is Provoked by 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ileitis in Rats.Visceral pain triggered by traction on the ileocecal ligament with ileitis.
P2860
Q28362604-06EE1A7B-1F5D-45AA-AB05-FB2BDCDA17EBQ28364168-2F8A2D97-FF0B-4BFB-8AE7-395A50BD513EQ33661077-A680654E-0D36-4B38-B1E7-80DCD46D67DCQ33701309-318143C8-DDED-42EB-A81E-6A542CFA0C85Q33717384-DAF1179E-060C-44C3-8694-8FCBEFB82212Q33735229-76E9188E-2538-4FB8-9C61-FCA7968B1690Q33774778-56A00599-117F-4940-9CAB-226DCED95F60Q33875272-4EDF231D-088B-499E-A824-67386F5EFB38Q33912707-543C74C2-2266-43EE-B1ED-25B8F437A3B4Q33928109-A2A8D344-20A6-49C7-B20B-024C2CB70936Q33945979-D1232E31-FE6B-4A6A-9C36-50D859C81EE6Q34074642-404B86BA-5463-4563-B981-35C836401A26Q34081779-0AD60970-EC43-4116-86F3-62780FE8044CQ34089180-55A8D377-11B2-4020-A410-8F94548DC97FQ34100126-39555A05-41C2-419B-AE1B-904092225E30Q34134491-92EB409D-42FF-4D53-B8B0-410505030003Q34481528-6DC2A495-7940-4188-85AA-69558650558FQ34612205-B5CA39C5-B97A-475B-A851-A6234BD96514Q34626602-9B57C5DA-8CD1-4891-BA85-54B40C16D945Q34699809-FD8CFBC3-0C94-457B-859F-BBE0D962CD1EQ34699839-244BBB0A-5449-42EF-8262-797EBE7E7DCFQ34699852-2194C589-0A6A-4586-A392-219F9C8FD6D1Q34699864-AA7C97F4-05BE-4702-9075-41B9FFA6D7AEQ34928837-0B939728-AAC5-4867-9E62-89BE9065D99BQ35596749-11BD8E9C-77E0-48E9-9857-936A88BDF401Q35611918-3C78A231-9D24-42BB-967F-61F1689A9069Q35753361-BC44FA30-48D0-4884-9C8D-22B747D6786BQ35948222-2589879D-BD62-4C7D-B238-7B764B965557Q36066001-315ECB56-3E97-497E-BD06-BEFADC6C3363Q36182806-48311B61-B510-49BA-BCB5-11AA3C8FBEA0Q36349789-94874D34-F846-4C83-ADD0-E095A55A6E37Q36478102-0DE11629-469D-4F8E-A500-609B2E5B7CD7Q36485745-1D5C230B-6BA0-4AEC-84CA-5E21312DA06BQ36485768-5EFACA21-02BA-45A8-824F-556FEE603D9DQ36529154-36D91247-5C58-4884-9DAF-E306FBFF99EEQ36609410-08513A81-681E-4C5D-BD9B-79B1B84566C3Q36676300-54BEDB61-0D4C-4980-8948-42041EC02603Q36848940-91E61D9C-9213-4705-A500-039C2A539C86Q37116356-4678CA7A-E1A3-4C17-A246-A4E9832516D4Q37316831-EC3489AB-90E5-48C9-90E2-E6EC3C40BF20
P2860
Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Mediators and pharmacology of ...... ic to clinical investigations.
@en
type
label
Mediators and pharmacology of ...... ic to clinical investigations.
@en
prefLabel
Mediators and pharmacology of ...... ic to clinical investigations.
@en
P2093
P1433
P1476
Mediators and pharmacology of ...... ic to clinical investigations.
@en
P2093
P304
P356
10.1016/S0016-5085(97)70056-8
P407
P577
1997-05-01T00:00:00Z